Literature DB >> 30817438

The role of afferent input in postamputation pain: a randomized, double-blind, placebo-controlled crossover study.

Nina Stockfleth Buch1,2, Peter Ahlburg1, Simon Haroutounian3, Niels Trolle Andersen4, Nanna Brix Finnerup2,5, Lone Nikolajsen1.   

Abstract

In this randomized, double-blind, placebo-controlled crossover study, we investigated whether a peripheral nerve block could temporarily eliminate phantom and stump pain after amputation. Amputees with constant postamputation pain were included and randomized to receive a nerve block with lidocaine 2% with adrenaline or saline in a crossover design. Spontaneous phantom and stump pain and evoked responses were assessed at baseline and at fixed time-points until 120 minutes after lidocaine or saline injection. The primary outcome was the difference in absolute change between worst pain intensity, either phantom or stump pain, at baseline and at 30 minutes after lidocaine or saline injection. Twelve amputees were randomized and 9 patients were included in the analysis. The absolute change in median worst pain intensity between lidocaine and saline injection was -2.0 (interquartile range, -4.0 to 0.0) (n = 9, P = 0.12). Nine of 9 patients reported at least some pain relief after lidocaine injection compared with only 2 of 9 patients after saline injection (P = 0.02). Phantom pain intensity was significantly reduced after lidocaine compared with saline injection (P = 0.04), whereas there was no significant change in stump pain intensity between the 2 interventions (P = 0.17). In all 9 amputees, evoked responses were eliminated after lidocaine injection. Thus, our findings suggest that afferent input from the peripheral nervous system plays an important role in postamputation pain.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30817438     DOI: 10.1097/j.pain.0000000000001536

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  8 in total

Review 1.  Status of peripheral sodium channel blockers for non-addictive pain treatment.

Authors:  Matthew Alsaloum; Grant P Higerd; Philip R Effraim; Stephen G Waxman
Journal:  Nat Rev Neurol       Date:  2020-10-27       Impact factor: 42.937

2.  Adaptive mechanisms driving maladaptive pain: how chronic ongoing activity in primary nociceptors can enhance evolutionary fitness after severe injury.

Authors:  Edgar T Walters
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-09-23       Impact factor: 6.237

3.  Transcriptional Profiling of Non-injured Nociceptors After Spinal Cord Injury Reveals Diverse Molecular Changes.

Authors:  Jessica R Yasko; Isaac L Moss; Richard E Mains
Journal:  Front Mol Neurosci       Date:  2019-11-26       Impact factor: 5.639

4.  Contributions of NaV1.8 and NaV1.9 to excitability in human induced pluripotent stem-cell derived somatosensory neurons.

Authors:  Matthew Alsaloum; Julie I R Labau; Shujun Liu; Mark Estacion; Peng Zhao; Fadia Dib-Hajj; Stephen G Waxman
Journal:  Sci Rep       Date:  2021-12-20       Impact factor: 4.379

Review 5.  Peripheral Voltage-Gated Cation Channels in Neuropathic Pain and Their Potential as Therapeutic Targets.

Authors:  Sascha R A Alles; Peter A Smith
Journal:  Front Pain Res (Lausanne)       Date:  2021-12-13

6.  Electroacupuncture For Alleviation Of Phantom Limb Pain.

Authors:  Holly King; Max Forrester
Journal:  J Rehabil Med Clin Commun       Date:  2021-05-31

7.  John J. Bonica Award Lecture: Peripheral neuronal hyperexcitability: the "low-hanging" target for safe therapeutic strategies in neuropathic pain.

Authors:  Srinivasa N Raja; Matthias Ringkamp; Yun Guan; James N Campbell
Journal:  Pain       Date:  2020-09       Impact factor: 7.926

8.  Genomic analysis of 21 patients with corneal neuralgia after refractive surgery.

Authors:  Jun-Hui Yuan; Betsy R Schulman; Philip R Effraim; Dib-Hajj Sulayman; Deborah S Jacobs; Stephen G Waxman
Journal:  Pain Rep       Date:  2020-07-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.